Rare diseases
Investigational molecules
Locations
No. 666 Xinhuaavenue, Chengduhaixialiangantechnologyindustrydevelopmentpark, 610072
Clinical research activity includes metastatic and locally advanced unresectable solid tumors that have progressed after standard therapies, with attention to treatment-resistant disease settings and tumour response in heavily pretreated populations.
The sponsor’s oncology portfolio in this area reflects a strong interest in late-line cancer treatment across heterogeneous solid malignancies.
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. runs clinical trials in conditions such as Non-small cell lung cancer, Neoplasm malignant, Endometrial cancer, Transitional cell carcinoma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Romania
Italy
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
